Teijin EBITDA Margin 2010-2024 | TINLY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Teijin (TINLY) over the last 10 years. The current EBITDA margin for Teijin as of June 30, 2024 is .
Teijin EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2024-06-30 |
$7.36B |
$0.44B |
6.02% |
2023-06-30 |
$7.39B |
$0.39B |
5.25% |
2022-06-30 |
$7.55B |
$0.51B |
6.77% |
2021-06-30 |
$7.67B |
$0.60B |
7.77% |
2020-06-30 |
$7.39B |
$0.61B |
8.26% |
2019-06-30 |
$7.35B |
$0.64B |
8.71% |
2018-06-30 |
$6.97B |
$0.62B |
8.90% |
2017-06-30 |
$6.73B |
$2.20B |
32.67% |
2016-06-30 |
$6.71B |
$3.80B |
56.53% |
2015-06-30 |
$6.97B |
$5.53B |
79.28% |
2015-03-31 |
$7.16B |
$5.43B |
75.77% |
2014-12-31 |
$7.44B |
$5.71B |
76.69% |
2014-09-30 |
$7.64B |
$5.90B |
77.29% |
2014-06-30 |
$7.77B |
$6.03B |
77.66% |
2014-03-31 |
$7.85B |
$6.01B |
76.62% |
2013-12-31 |
$7.87B |
$6.03B |
76.68% |
2013-09-30 |
$8.18B |
$6.34B |
77.56% |
2013-06-30 |
$8.51B |
$6.68B |
78.44% |
2013-03-31 |
$8.84B |
$6.69B |
75.76% |
2012-12-31 |
$10.03B |
$7.89B |
78.64% |
2012-09-30 |
$10.36B |
$8.22B |
79.33% |
2012-06-30 |
$10.66B |
$8.52B |
79.90% |
2012-03-31 |
$10.81B |
$8.61B |
79.69% |
2011-12-31 |
$10.12B |
$7.92B |
78.29% |
2011-09-30 |
$10.01B |
$7.81B |
78.06% |
2011-06-30 |
$9.80B |
$5.50B |
56.14% |
2011-03-31 |
$9.57B |
$5.61B |
58.58% |
2010-12-31 |
$9.29B |
$3.24B |
34.86% |
2010-09-30 |
$9.01B |
$1.02B |
11.32% |
2010-06-30 |
$8.67B |
$0.92B |
10.58% |
2010-03-31 |
$8.28B |
$0.82B |
9.88% |
Sector |
Industry |
Market Cap |
Revenue |
Consumer Discretionary |
Textile - Apparel Manufacturing |
$1.638B |
$7.154B |
Teijin Limited is involved in the manufacture, processing and sale of chemical products. Advanced Fibers & Composites segment is engaged in the manufacture and sale of aramid fiber (such as yarn, cotton, woven or knitted fabric), carbon fiber products and polyester fiber (industrial materials). Electric Materials & Chemical Products segment involves in the manufacture and sale of films, resins and resin products. Healthcare segment involves in the manufacture and sale of pharmaceuticals and home medical care equipment, as well as the clinical development of new drugs. Products Converting segment involves in the planning, processing and sale of textile products. Others segment involves in the operation, development and maintenance of information systems, as well as the provision of printing services.
|